David Domzalski insider trades

Open-market stock purchases and sales by David Domzalski, PRESIDENT AND CEO at VYNE Therapeutics Inc, from SEC Form 4 filings since Jan 1, 2018.

Recent trades

DateStockTradeValue
Jul 23, 2026VYNE VYNE Therapeutics IncSold (not open market)$71.3K
May 29, 2026VYNE VYNE Therapeutics IncBought (not open market)$9.5K
Mar 31, 2026VYNE VYNE Therapeutics IncSold (not open market)$8.5K
Dec 31, 2025VYNE VYNE Therapeutics IncSold (not open market)$7.4K

Companies traded

  • VYNE VYNE Therapeutics Inc: 1 buy, last Jul 23, 2026
  • MNLO Menlo Therapeutics Inc: other filings, last Jun 30, 2020
  • FOMX Foamix Pharmaceuticals Ltd: 12 sales, last Mar 9, 2020

Get free alerts when David Domzalski files a new trade →